DLEU1 and Pain: Since DLEU1 was reported to serve as a competitive endogenous RNA (ceRNA) at the post-transcriptional level in various diseases (Chen et al. 2019; Feng et al. 2019; Li et al. 2020b), we aimed to explore whether DLEU1 can serve as a ceRNA in neuropathic pain.